Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 325
Selected: 0
NCT IDTitle
NCT05274880Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393
NCT01001611An Evaluation of Glycemic Control Effects of Mono Therapy CKD-501 in Patients With Type 2 Diabetes Mellitus
NCT03076957A Phase 1/2a Study to Assess the Safety and Efficacy of CKD-516 Tab. in Combination With Irinotecan Inj.
NCT02777723Study to Evaluate the Efficacy and Safety of CKD-350
NCT03175835Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects
NCT01560325Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers
NCT06695572Clinical Study to Evaluate the Food Effect of CKD-383 0.5/10/1000mg in Healthy Volunteers
NCT02451098Clinical Trial to Evaluate the Efficacy and Safety of CKD-391
NCT00826644Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient
NCT02159976Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea
NCT03609606A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects
NCT05552495Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fasting Conditions
NCT03713892CKD-504 in SAD and MAD in Healthy Korean and Caucasian Adult Male and Female Subjects
NCT03794492Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome
NCT03849261Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults
NCT07358156A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants.
NCT05041790A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
NCT01819870Study to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32mg and Dilatrend Tablet 25mg
NCT05189288Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388(2) in Healthy Subjects
NCT04156685Pharmacokinetics, Safety and Tolerability of CKD-387 10/500mg BE Phase1
NCT05928637A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150
NCT04857177A Study To Evaluate CKD-701 and Lucentis® in Patients With Neovascular(Wet) Age Related Macular Degeneration
NCT02526875Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled
NCT07258745Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (Risankizumab Biosimilar), With EU-approved Skyrizi®, and US-licensed Skyrizi® in Healthy Adult Participants
NCT01910077Bioequivalence Study of Tacrobell Capsule 1mg to Prograf Capsule 1mg
NCT05952219Study to Evaluate the Safety and Pharmacokinetics of CKD-379
NCT05347576A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions
NCT07365358Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus Patients
NCT03739125Efficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 Diabetes
NCT04660370A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348
NCT01005160Drug Interaction Between CKD-501 and Metformin
NCT04673682A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-845
NCT07304687Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/25/1000mg in Healthy Volunteers
NCT04075643Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy Volunteers
NCT04488900Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects
NCT01860482The Study to Evaluate Efficacy and Safety of Newrabell® Tab.(Rabeprazole Sodium) 10mg b.i.d in Refractory GERD
NCT05921435Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D958 in Healthy Adults
NCT01356017CKD-828 Drug Interaction Study (Telmisartan)
NCT03414840Assessment of Change in Atherosclerotic Plaque by Serial CCTA
NCT05238948CKD-506 Drug-Drug Interaction Study in Healthy Male Subjects
NCT01766505The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR)
NCT05549401Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348
NCT01162005Therapeutic Effect of Tacrolimus on Primary Nephrotic Syndrome in Children
NCT06044493MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients
NCT02250833CKD-828 (80/5mg) Pharmacokinetic Study
NCT03950843A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation
NCT03849495Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-370 and D745 in Healthy Adults
NCT03749356Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients
NCT05749861A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)
NCT05540912Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-828 in Healthy Subjects